X4 Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule i…

Biotechnology
US, Boston [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of XFOR's Analysis
CIK: 1501697 CUSIP: 98420X103 ISIN: US98420X1037 LEI: - UEI: -
Secondary Listings
XFOR has no secondary listings inside our databases.